June 25, 2008 / 8:37 PM / 10 years ago

Panel recommends Glaxo's new diarrhea vaccine

WASHINGTON (Reuters) - U.S. government experts recommended GlaxoSmithKline Plc’s Rotarix vaccine to prevent infant diarrhea on Wednesday, giving doctors and parents two choices of oral vaccines to protect against rotavirus.

Glaxo said the Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices recommended adding Rotarix to the choices for immunizing infants against the sometimes deadly intestinal virus. Merck and Co Inc’s Rotateq is also recommended, and the panel says both are equally effective.

Reporting by Maggie Fox; editing by Jeffrey Benkoe

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below